Literature DB >> 32447502

Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer.

Daniel S Childs1, Harry H Yoon1, Rachel A Eiring1, Zhaohui Jin1, Jacob A Jochum1, Henry C Pitot1, Aminah Jatoi2.   

Abstract

PURPOSE: Falls can occur in older cancer patients, but few studies have examined falls in an age-unspecified group of patients with locally advanced esophageal cancer. Because these patients are often administered neuropathy-inducing agents, are weak, and can develop orthostatic symptoms, examining falls appears relevant.
METHODS: Electronic medical records were used to examine falls and their circumstances in locally advanced esophageal cancer patients treated with chemotherapy and radiation and often surgery.
RESULTS: Among 300 patients, 62 (21%) suffered a fall, yielding 6 falls per 100 patient years. The median age at first fall was 64 years (range 31 to 83). The median time from cancer diagnosis to first fall was 11 months (range 0 to 107). Forty-two patients (68%) who fell had active cancer; 20 (32%) were cancer-free. Fall-related injuries occurred in 42 patients and included fractures, hematomas, and other musculoskeletal events. Eighteen patients (29%) fell repeatedly. Neuropathy, general weakness, and orthostatic symptoms were associated with falls ("He does state his neuropathy is more bothersome…. He did have a fall last week…." "He has been increasingly weak to the point where he fell down last week…." "Upon rising… [he] felt like somebody had put a sheet over his eyes, felt very lightheaded, and fell to the floor…."). At times, falls occurred under commonplace circumstances, such as slipping on ice or tripping on an underfoot pet.
CONCLUSION: Regardless of patient age, clinicians should remain vigilant for fall risk in adult patients with locally advanced esophageal cancer.

Entities:  

Keywords:  Esophageal cancer; Falls; Fracture; Neuropathy; Younger patients

Mesh:

Year:  2020        PMID: 32447502      PMCID: PMC7683374          DOI: 10.1007/s00520-020-05511-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  2 in total

1.  Psychosocial adaptation and influencing factors among patients with chemotherapy-induced peripheral neuropathy.

Authors:  Xiao Zhou; Dong-Yang Wang; Cai-Yan Ding; Hui Liu; Zhi-Qin Sun
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

2.  A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma.

Authors:  Rajabali Daroudi; Azin Nahvijou; Mohammad Arab; Ahmad Faramarzi; Bita Kalaghchi; Ali Akbari Sari; Javad Javan-Noughabi
Journal:  Cost Eff Resour Alloc       Date:  2022-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.